Some studies have shown that CD68+ TAMs are mostly distributed in CRC tumor stroma, mainly along the front edge of the invasion, and CD68+ TAMs infiltrated into this site can improve the prognosis of CRC patients [155,156,164,165]. The gene discussed is CD68; the disease is neoplasm.